{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,19]],"date-time":"2026-07-19T17:10:54Z","timestamp":1784481054163,"version":"3.55.0"},"reference-count":273,"publisher":"Elsevier","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025]]},"DOI":"10.1016\/bs.apcsb.2024.11.012","type":"book-chapter","created":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T19:24:18Z","timestamp":1747077858000},"source":"Crossref","is-referenced-by-count":2,"title":["Tau protein aggregation: A therapeutic target for neurodegenerative diseases"],"prefix":"10.1016","author":[{"given":"Aryan","family":"Duggal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Drishti","family":"Mahindru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirti","family":"Baghel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjana","family":"Mehrotra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay Kumar","family":"Prajapati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/bs.apcsb.2024.11.012_bib1","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/s42003-024-05920-4","article-title":"Phosphorylation regulates tau\u2019s phase separation behavior and interactions with chromatin","volume":"7","author":"Abasi","year":"2024","journal-title":"Communications Biology"},{"issue":"1","key":"10.1016\/bs.apcsb.2024.11.012_bib2","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1038\/s41467-017-01068-4","article-title":"Cis P-tau is induced in clinical and preclinical brain injury and contributes to post-injury sequelae","volume":"8","author":"Albayram","year":"2017","journal-title":"Nature Communications"},{"issue":"2","key":"10.1016\/bs.apcsb.2024.11.012_bib3","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1136\/jnnp.37.2.121","article-title":"The \u2018subcortical dementia\u2019 of progressive supranuclear palsy","volume":"37","author":"Albert","year":"1974","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"key":"10.1016\/bs.apcsb.2024.11.012_bib4","doi-asserted-by":"crossref","first-page":"338","DOI":"10.3389\/fncel.2018.00338","article-title":"Hyperphosphorylation of Tau associates with changes in its function beyond microtubule stability","volume":"12","author":"Alonso","year":"2018","journal-title":"Frontiers in Cellular Neuroscience"},{"key":"10.1016\/bs.apcsb.2024.11.012_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174178","article-title":"siRNA: Mechanism of action, challenges, and therapeutic approaches","volume":"905","author":"Alshaer","year":"2021","journal-title":"European Journal of Pharmacology"},{"issue":"2\u20133","key":"10.1016\/bs.apcsb.2024.11.012_bib6","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.bbadis.2004.08.010","article-title":"Tau gene alternative splicing: Expression patterns, regulation and modulation of function in normal brain and neurodegenerative diseases","volume":"1739","author":"Andreadis","year":"2005","journal-title":"Biochimica et Biophysica Acta"},{"issue":"22","key":"10.1016\/bs.apcsb.2024.11.012_bib7","doi-asserted-by":"crossref","first-page":"8673","DOI":"10.3390\/ijms21228673","article-title":"Current progress and future directions for Tau-based fluid biomarker diagnostics in Alzheimer\u2019s disease","volume":"21","author":"Arastoo","year":"2020","journal-title":"International Journal of Molecular Sciences"},{"issue":"46","key":"10.1016\/bs.apcsb.2024.11.012_bib8","doi-asserted-by":"crossref","first-page":"28741","DOI":"10.1074\/jbc.271.46.28741","article-title":"The microtubule-associated protein tau is extensively modified with O-linked N-acetylglucosamine","volume":"271","author":"Arnold","year":"1996","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/bs.apcsb.2024.11.012_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.103836","article-title":"Cerebrospinal fluid p-tau231 as an early indicator of emerging pathology in Alzheimer\u2019s disease","volume":"76","author":"Ashton","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/bs.apcsb.2024.11.012_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2020.630743","article-title":"Impact of chaperone-mediated autophagy in brain aging: Neurodegenerative diseases and glioblastoma","volume":"12","author":"Auzmendi-Iriarte","year":"2021","journal-title":"Frontiers in Aging Neuroscience"},{"issue":"1","key":"10.1016\/bs.apcsb.2024.11.012_bib11","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/s13195-024-01545-1","article-title":"Rationale and design of the BeyeOMARKER study: Prospective evaluation of blood- and eye-based biomarkers for early detection of Alzheimer\u2019s disease pathology in the eye clinic","volume":"16","author":"Bader","year":"2024","journal-title":"Alzheimer\u2019s Research & Therapy"},{"key":"10.1016\/bs.apcsb.2024.11.012_bib12","doi-asserted-by":"crossref","first-page":"204","DOI":"10.3389\/fnagi.2019.00204","article-title":"Role of Tau as a microtubule-associated protein: Structural and functional aspects","volume":"11","author":"Barbier","year":"2019","journal-title":"Frontiers in Aging Neuroscience"},{"issue":"8","key":"10.1016\/bs.apcsb.2024.11.012_bib13","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1038\/78682","article-title":"Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease","volume":"6","author":"Bard","year":"2000","journal-title":"Nature Medicine"},{"issue":"5","key":"10.1016\/bs.apcsb.2024.11.012_bib14","doi-asserted-by":"crossref","first-page":"a025817","DOI":"10.1101\/cshperspect.a025817","article-title":"Microtubule-based transport and the distribution, tethering, and organization of organelles","volume":"9","author":"Barlan","year":"2017","journal-title":"Cold Spring Harbor Perspectives in Biology"},{"issue":"8","key":"10.1016\/bs.apcsb.2024.11.012_bib15","first-page":"1421","article-title":"Oxidative stress in tauopathies: from cause to therapy","volume":"11","author":"Bartolome","year":"2022","journal-title":"Antioxidants (Basel, Switzerland)"},{"issue":"1","key":"10.1016\/bs.apcsb.2024.11.012_bib16","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00401-009-0522-3","article-title":"Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer\u2019s disease","volume":"118","author":"Bell","year":"2009","journal-title":"Acta Neuropathologica"},{"issue":"6","key":"10.1016\/bs.apcsb.2024.11.012_bib17","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1097\/00005072-199706000-00010","article-title":"Cortical degeneration in progressive supranuclear palsy. A comparison with cortical-basal ganglionic degeneration","volume":"56","author":"Bergeron","year":"1997","journal-title":"Journal of Neuropathology and Experimental Neurology"},{"issue":"4","key":"10.1016\/bs.apcsb.2024.11.012_bib18","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1083\/jcb.101.4.1371","article-title":"The distribution of tau in the mammalian central nervous system","volume":"101","author":"Binder","year":"1985","journal-title":"The Journal of Cell Biology"},{"issue":"10","key":"10.1016\/bs.apcsb.2024.11.012_bib19","doi-asserted-by":"crossref","first-page":"4158","DOI":"10.1172\/JCI69003","article-title":"Accelerated neurodegeneration through chaperone-mediated oligomerization of tau","volume":"123","author":"Blair","year":"2013","journal-title":"The Journal of Clinical Investigation"},{"issue":"47","key":"10.1016\/bs.apcsb.2024.11.012_bib20","doi-asserted-by":"crossref","first-page":"19209","DOI":"10.1074\/jbc.M117.815126","article-title":"An inhibitor of the proteasomal deubiquitinating enzyme USP14 induces tau elimination in cultured neurons","volume":"292","author":"Boselli","year":"2017","journal-title":"The Journal of Biological Chemistry"},{"issue":"6","key":"10.1016\/bs.apcsb.2024.11.012_bib21","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S1474-4422(19)30139-5","article-title":"Safety of the tau-directed monoclonal antibody BIIB092 in progressive supranuclear palsy: A randomised, placebo-controlled, multiple ascending dose phase 1b trial","volume":"18","author":"Boxer","year":"2019","journal-title":"The Lancet. Neurology"},{"issue":"4","key":"10.1016\/bs.apcsb.2024.11.012_bib22","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathologica"},{"issue":"5","key":"10.1016\/bs.apcsb.2024.11.012_bib23","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1083\/jcb.131.5.1327","article-title":"Interaction of Tau with the neural plasma membrane mediated by Tau\u2019s amino-terminal projection domain","volume":"131","author":"Brandt","year":"1995","journal-title":"The Journal of Cell Biology"},{"key":"10.1016\/bs.apcsb.2024.11.012_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.590059","article-title":"Much more than a cytoskeletal protein: Physiological and pathological functions of the non-microtubule binding region of Tau","volume":"11","author":"Brandt","year":"2020","journal-title":"Frontiers in Neurology"},{"issue":"4","key":"10.1016\/bs.apcsb.2024.11.012_bib25","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/1074-5521(94)90014-0","article-title":"A DNA enzyme that cleaves RNA","volume":"1","author":"Breaker","year":"1994","journal-title":"Chemistry & Biology"},{"issue":"2","key":"10.1016\/bs.apcsb.2024.11.012_bib26","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1006\/exnr.1993.1059","article-title":"Serum proteins bypass the blood-brain fluid barriers for extracellular entry to the central nervous system","volume":"120","author":"Broadwell","year":"1993","journal-title":"Experimental Neurology"},{"issue":"3","key":"10.1016\/bs.apcsb.2024.11.012_bib27","first-page":"535","article-title":"Pick\u2019s disease","volume":"1","author":"Brown","year":"1992","journal-title":"Bailliere\u2019s Clinical Neurology"},{"issue":"9","key":"10.1016\/bs.apcsb.2024.11.012_bib28","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1007\/s00018-019-03349-1","article-title":"Mechanisms of secretion and spreading of pathological tau protein","volume":"77","author":"Brunello","year":"2020","journal-title":"Cellular and Molecular Life Sciences: CMLS"},{"issue":"1","key":"10.1016\/bs.apcsb.2024.11.012_bib29","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0165-0173(00)00019-9","article-title":"Tau protein isoforms, phosphorylation and role in neurodegenerative disorders","volume":"33","author":"Bu\u00e9e","year":"2000","journal-title":"Brain Research Reviews"},{"issue":"4","key":"10.1016\/bs.apcsb.2024.11.012_bib30","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s004010050436","article-title":"Hyperphosphorylated Tau proteins differentiate corticobasal degeneration and Pick\u2019s disease","volume":"91","author":"Bu\u00e9e Scherrer","year":"1996","journal-title":"Acta Neuropathologica"},{"issue":"1","key":"10.1016\/bs.apcsb.2024.11.012_bib31","doi-asserted-by":"crossref","DOI":"10.1111\/acel.12692","article-title":"Interplay of pathogenic forms of human tau with different autophagic pathways","volume":"17","author":"Caballero","year":"2018","journal-title":"Aging Cell"},{"issue":"6","key":"10.1016\/bs.apcsb.2024.11.012_bib32","doi-asserted-by":"crossref","first-page":"667","DOI":"10.3390\/genes11060667","article-title":"Development of novel chemically-modified nucleic acid molecules for efficient inhibition of human MAPT gene expression","volume":"11","author":"Chakravarthy","year":"2020","journal-title":"Genes"},{"issue":"52","key":"10.1016\/bs.apcsb.2024.11.012_bib33","doi-asserted-by":"crossref","first-page":"54716","DOI":"10.1074\/jbc.M403364200","article-title":"Glycogen synthase kinase 3 beta induces caspase-cleaved tau aggregation in situ","volume":"279","author":"Cho","year":"2004","journal-title":"The Journal of Biological Chemistry"},{"issue":"2","key":"10.1016\/bs.apcsb.2024.11.012_bib34","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s00401-018-1948-2","article-title":"Novel tau fragments in cerebrospinal fluid: Relation to tangle pathology and cognitive decline in Alzheimer\u2019s disease","volume":"137","author":"Cicognola","year":"2019","journal-title":"Acta Neuropathologica"},{"issue":"10","key":"10.1016\/bs.apcsb.2024.11.012_bib35","doi-asserted-by":"crossref","first-page":"918","DOI":"10.2174\/1567205011666141107150331","article-title":"Structure and mechanism of action of tau aggregation inhibitors","volume":"11","author":"Cisek","year":"2014","journal-title":"Current Alzheimer Research"},{"issue":"7","key":"10.1016\/bs.apcsb.2024.11.012_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0158470","article-title":"Intrinsic Tau acetylation is coupled to auto-proteolytic Tau fragmentation","volume":"11","author":"Cohen","year":"2016","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/bs.apcsb.2024.11.012_bib37","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/nsmb.2555","article-title":"The microtubule-associated Tau protein has intrinsic acetyltransferase activity","volume":"20","author":"Cohen","year":"2013","journal-title":"Nature Structural & Molecular Biology"},{"key":"10.1016\/bs.apcsb.2024.11.012_bib38","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/978-0-387-46401-5_8","article-title":"Neuroprotective effects of curcumin","volume":"595","author":"Cole","year":"2007","journal-title":"Advances in Experimental Medicine and Biology"},{"issue":"Pt 10","key":"10.1016\/bs.apcsb.2024.11.012_bib39","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.1093\/brain\/awu213","article-title":"Neuronal uptake of Tau\/pS422 antibody and reduced progression of Tau pathology in a mouse model of Alzheimer\u2019s disease","volume":"137","author":"Collin","year":"2014","journal-title":"Brain: A Journal of Neurology"},{"key":"10.1016\/bs.apcsb.2024.11.012_bib40","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/978-981-32-9358-8_7","article-title":"Tau and axonal transport misregulation in tauopathies","volume":"1184","author":"Combs","year":"2019","journal-title":"Advances in Experimental Medicine and Biology"},{"issue":"46","key":"10.1016\/bs.apcsb.2024.11.012_bib41","article-title":"A\u03b2 and Tau prions feature in the neuropathogenesis of Down syndrome","volume":"119","author":"Condello","year":"2022","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"7","key":"10.1016\/bs.apcsb.2024.11.012_bib42","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/s41582-018-0013-z","article-title":"Tau-targeting therapies for Alzheimer disease","volume":"14","author":"Congdon","year":"2018","journal-title":"Nature Reviews. Neurology"},{"issue":"4","key":"10.1016\/bs.apcsb.2024.11.012_bib43","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1159\/000114320","article-title":"Pick\u2019s disease. Histological and clinical correlations","volume":"11","author":"Constantinidis","year":"1974","journal-title":"European Neurology"},{"issue":"1","key":"10.1016\/bs.apcsb.2024.11.012_bib44","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1093\/hmg\/ddt402","article-title":"Acetylation of the KXGS motifs in tau is a critical determinant in modulation of tau aggregation and clearance","volume":"23","author":"Cook","year":"2014","journal-title":"Human Molecular Genetics"},{"issue":"22","key":"10.1016\/bs.apcsb.2024.11.012_bib45","doi-asserted-by":"crossref","first-page":"15721","DOI":"10.1016\/S0021-9258(19)49595-1","article-title":"Microtubule-associated protein tau is phosphorylated by protein kinase C on its tubulin binding domain","volume":"267","author":"Correas","year":"1992","journal-title":"The Journal of Biological Chemistry"},{"issue":"9","key":"10.1016\/bs.apcsb.2024.11.012_bib46","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s11910-017-0779-1","article-title":"Emerging diagnostic and therapeutic strategies for tauopathies","volume":"17","author":"Coughlin","year":"2017","journal-title":"Current Neurology and Neuroscience Reports"},{"issue":"5","key":"10.1016\/bs.apcsb.2024.11.012_bib47","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1038\/cdd.2014.179","article-title":"GSK-3\u03b2 dysregulation contributes to parkinson\u2019s-like pathophysiology with associated region-specific phosphorylation and accumulation of tau and \u03b1-synuclein","volume":"22","author":"Credle","year":"2015","journal-title":"Cell Death and Differentiation"},{"issue":"16","key":"10.1016\/bs.apcsb.2024.11.012_bib48","doi-asserted-by":"crossref","first-page":"11024","DOI":"10.1074\/jbc.M112.436006","article-title":"Aminothienopyridazines and methylene blue affect Tau fibrillization via cysteine oxidation","volume":"288","author":"Crowe","year":"2013","journal-title":"The Journal of Biological Chemistry"},{"issue":"6","key":"10.1016\/bs.apcsb.2024.11.012_bib49","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1073\/pnas.88.6.2288","article-title":"Straight and paired helical filaments in Alzheimer disease have a common structural unit","volume":"88","author":"Crowther","year":"1991","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"3","key":"10.1016\/bs.apcsb.2024.11.012_bib50","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0896-6273(03)00627-5","article-title":"Aberrant Cdk5 activation by p25 triggers pathological events leading to neurodegeneration and neurofibrillary tangles","volume":"40","author":"Cruz","year":"2003","journal-title":"Neuron"},{"issue":"5688","key":"10.1016\/bs.apcsb.2024.11.012_bib51","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1126\/science.1101738","article-title":"Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy","volume":"305","author":"Cuervo","year":"2004","journal-title":"Science (New York, N. Y.)"},{"issue":"8","key":"10.1016\/bs.apcsb.2024.11.012_bib52","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1001\/archneur.1984.04050190080019","article-title":"Subcortical dementia. Review of an emerging concept","volume":"41","author":"Cummings","year":"1984","journal-title":"Archives of Neurology"},{"issue":"8","key":"10.1016\/bs.apcsb.2024.11.012_bib53","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0135774","article-title":"Passive immunization in JNPL3 transgenic mice using an array of phospho-tau specific antibodies","volume":"10","author":"d\u2019Abramo","year":"2015","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/bs.apcsb.2024.11.012_bib54","doi-asserted-by":"crossref","first-page":"277","DOI":"10.5114\/fn.2018.80859","article-title":"Argyrophilic grain disease: A clinicopathological review of an overlooked tauopathy","volume":"56","author":"Das","year":"2018","journal-title":"Folia Neuropathologica"},{"issue":"6","key":"10.1016\/bs.apcsb.2024.11.012_bib55","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1212\/WNL.52.6.1158","article-title":"The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer\u2019s disease","volume":"52","author":"Delacourte","year":"1999","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/bs.apcsb.2024.11.012_bib56","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/BF00308912","article-title":"Pathological proteins Tau 64 and 69 are specifically expressed in the somatodendritic domain of the degenerating cortical neurons during Alzheimer\u2019s disease. Demonstration with a panel of antibodies against Tau proteins","volume":"80","author":"Delacourte","year":"1990","journal-title":"Acta Neuropathologica"},{"issue":"2","key":"10.1016\/bs.apcsb.2024.11.012_bib57","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/00005072-199602000-00004","article-title":"Specific pathological Tau protein variants characterize Pick\u2019s disease","volume":"55","author":"Delacourte","year":"1996","journal-title":"Journal of Neuropathology and Experimental Neurology"},{"key":"10.1016\/bs.apcsb.2024.11.012_bib58","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.2147\/NDT.S106479","article-title":"A new look at an old drug: Neuroprotective effects and therapeutic potentials of lithium salts","volume":"12","author":"Dell\u2019Osso","year":"2016","journal-title":"Neuropsychiatric Disease and Treatment"},{"issue":"374","key":"10.1016\/bs.apcsb.2024.11.012_bib59","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aag0481","article-title":"Tau reduction prevents neuronal loss and reverses pathological tau deposition and seeding in mice with tauopathy","volume":"9","author":"DeVos","year":"2017","journal-title":"Science Translational Medicine"},{"issue":"3","key":"10.1016\/bs.apcsb.2024.11.012_bib60","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1172\/JCI29715","article-title":"The high-affinity HSP90-CHIP complex recognizes and selectively degrades phosphorylated tau client proteins","volume":"117","author":"Dickey","year":"2007","journal-title":"The Journal of Clinical Investigation"},{"issue":"15","key":"10.1016\/bs.apcsb.2024.11.012_bib61","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1039\/C5CC10301K","article-title":"Rational design and diversity-oriented synthesis of peptoid-based selective HDAC6 inhibitors","volume":"52","author":"Diedrich","year":"2016","journal-title":"Chemical communications (Cambridge, England)"},{"issue":"12","key":"10.1016\/bs.apcsb.2024.11.012_bib62","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1021\/cn200088r","article-title":"\u201cClicked\u201d sugar-curcumin conjugate: modulator of amyloid-\u03b2 and tau peptide aggregation at ultralow concentrations","volume":"2","author":"Dolai","year":"2011","journal-title":"ACS Chemical Neuroscience"},{"issue":"15","key":"10.1016\/bs.apcsb.2024.11.012_bib63","doi-asserted-by":"crossref","first-page":"9919","DOI":"10.1074\/jbc.M510127200","article-title":"Small ubiquitin-like modifier (SUMO) modification of natively unfolded proteins tau and alpha-synuclein","volume":"281","author":"Dorval","year":"2006","journal-title":"The Journal of Biological Chemistry"},{"issue":"52","key":"10.1016\/bs.apcsb.2024.11.012_bib64","doi-asserted-by":"crossref","first-page":"18213","DOI":"10.1074\/jbc.RA120.015882","article-title":"A combinatorial native MS and LC-MS\/MS approach reveals high intrinsic phosphorylation of human Tau but minimal levels of other key modifications","volume":"295","author":"Drepper","year":"2020","journal-title":"The Journal of Biological Chemistry"},{"issue":"6","key":"10.1016\/bs.apcsb.2024.11.012_bib65","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1002\/j.1460-2075.1992.tb05272.x","article-title":"Mitogen activated protein (MAP) kinase transforms tau protein into an Alzheimer-like state","volume":"11","author":"Drewes","year":"1992","journal-title":"The EMBO Journal"},{"issue":"9","key":"10.1016\/bs.apcsb.2024.11.012_bib66","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrd4360","article-title":"Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders","volume":"13","author":"Falkenberg","year":"2014","journal-title":"Nature Reviews. Drug Discovery"},{"issue":"1","key":"10.1016\/bs.apcsb.2024.11.012_bib67","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/00005072-199601000-00006","article-title":"Neuropathologic overlap of progressive supranuclear palsy, Pick\u2019s disease and corticobasal degeneration","volume":"55","author":"Feany","year":"1996","journal-title":"Journal of Neuropathology and Experimental Neurology"},{"issue":"1","key":"10.1016\/bs.apcsb.2024.11.012_bib68","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/NEN.0000000000000030","article-title":"Glial and neuronal tau pathology in tauopathies: Characterization of disease-specific phenotypes and tau pathology progression","volume":"73","author":"Ferrer","year":"2014","journal-title":"Journal of Neuropathology and Experimental Neurology"},{"issue":"Pt 6","key":"10.1016\/bs.apcsb.2024.11.012_bib69","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1093\/brain\/awm305","article-title":"Argyrophilic grain disease","volume":"131","author":"Ferrer","year":"2008","journal-title":"Brain: A Journal of Neurology"},{"issue":"2","key":"10.1016\/bs.apcsb.2024.11.012_bib70","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/BF00308927","article-title":"Correlation between microscopical changes and Tau 64 and 69 biochemical detection in senile dementia of the Alzheimer type. Tau 64 and 69 are reliable markers of the neurofibrillary degeneration","volume":"80","author":"Flament","year":"1990","journal-title":"Acta Neuropathologica"},{"issue":"7","key":"10.1016\/bs.apcsb.2024.11.012_bib71","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1001\/jamaneurol.2020.0528","article-title":"Positron emission tomography imaging with [18F]flortaucipir and postmortem assessment of Alzheimer disease neuropathologic changes","volume":"77","author":"Fleisher","year":"2020","journal-title":"JAMA Neurology"},{"issue":"13","key":"10.1016\/bs.apcsb.2024.11.012_bib72","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1212\/WNL.0b013e318230a16c","article-title":"Chronic divalproex sodium use and brain atrophy in Alzheimer disease","volume":"77","author":"Fleisher","year":"2011","journal-title":"Neurology"},{"issue":"7280","key":"10.1016\/bs.apcsb.2024.11.012_bib73","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/nature08908","article-title":"Cell mechanics and the cytoskeleton","volume":"463","author":"Fletcher","year":"2010","journal-title":"Nature"},{"issue":"14","key":"10.1016\/bs.apcsb.2024.11.012_bib74","doi-asserted-by":"crossref","first-page":"3971","DOI":"10.1093\/hmg\/ddv135","article-title":"The active Hsc70\/tau complex can be exploited to enhance tau turnover without damaging microtubule dynamics","volume":"24","author":"Fontaine","year":"2015","journal-title":"Human Molecular Genetics"},{"issue":"5","key":"10.1016\/bs.apcsb.2024.11.012_bib75","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1192\/bjp.bp.110.080044","article-title":"Disease-modifying properties of long-term lithium treatment for amnestic mild cognitive impairment: Randomised controlled trial","volume":"198","author":"Forlenza","year":"2011","journal-title":"The British Journal of Psychiatry: The Journal of Mental Science"},{"issue":"3","key":"10.1016\/bs.apcsb.2024.11.012_bib76","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/00005072-199603000-00001","article-title":"Neuropathology of Parkinson\u2019s disease","volume":"55","author":"Forno","year":"1996","journal-title":"Journal of Neuropathology and Experimental Neurology"},{"issue":"1","key":"10.1016\/bs.apcsb.2024.11.012_bib77","doi-asserted-by":"crossref","first-page":"6064","DOI":"10.1038\/s41598-020-62678-5","article-title":"Inhibition of HDAC6 activity protects dopaminergic neurons from alpha-synuclein toxicity","volume":"10","author":"Francelle","year":"2020","journal-title":"Scientific Reports"},{"issue":"2\u20133","key":"10.1016\/bs.apcsb.2024.11.012_bib78","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1007\/s12035-010-8137-1","article-title":"Why pleiotropic interventions are needed for Alzheimer\u2019s disease","volume":"41","author":"Frautschy","year":"2010","journal-title":"Molecular Neurobiology"},{"issue":"3","key":"10.1016\/bs.apcsb.2024.11.012_bib79","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.str.2020.01.004","article-title":"Structural characterization of tau in fuzzy tau:tubulin complexes","volume":"28","author":"Fung","year":"2020","journal-title":"Structure (London, England: 1993)"},{"issue":"1","key":"10.1016\/bs.apcsb.2024.11.012_bib80","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1042\/BJ20140372","article-title":"Lysine methylation is an endogenous post-translational modification of tau protein in human brain and a modulator of aggregation propensity","volume":"462","author":"Funk","year":"2014","journal-title":"The Biochemical Journal"},{"key":"10.1016\/bs.apcsb.2024.11.012_bib81","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3389\/fnins.2012.00104","article-title":"Tau protein and adult hippocampal neurogenesis","volume":"6","author":"Fuster-Matanzo","year":"2012","journal-title":"Frontiers in Neuroscience"},{"issue":"17","key":"10.1016\/bs.apcsb.2024.11.012_bib82","doi-asserted-by":"crossref","first-page":"10032","DOI":"10.1073\/pnas.1630428100","article-title":"Caspase cleavage of tau: Linking amyloid and neurofibrillary tangles in Alzheimer\u2019s disease","volume":"100","author":"Gamblin","year":"2003","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"8","key":"10.1016\/bs.apcsb.2024.11.012_bib83","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.it.2008.05.002","article-title":"Why neurodegenerative diseases are progressive: Uncontrolled inflammation drives disease progression","volume":"29","author":"Gao","year":"2008","journal-title":"Trends in Immunology"},{"issue":"21","key":"10.1016\/bs.apcsb.2024.11.012_bib84","doi-asserted-by":"crossref","first-page":"8065","DOI":"10.1074\/jbc.RA117.000490","article-title":"Annexins A2 and A6 interact with the extreme N terminus of tau and thereby contribute to tau\u2019s axonal localization","volume":"293","author":"Gauthier-Kemper","year":"2018","journal-title":"The Journal of Biological Chemistry"},{"issue":"3","key":"10.1016\/bs.apcsb.2024.11.012_bib85","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s004010050886","article-title":"Argyrophilic grain disease is associated with apolipoprotein E epsilon 2 allele","volume":"96","author":"Ghebremedhin","year":"1998","journal-title":"Acta Neuropathologica"},{"issue":"1","key":"10.1016\/bs.apcsb.2024.11.012_bib86","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s40478-024-01806-y","article-title":"Cryo-EM structures reveal tau filaments from Down syndrome adopt Alzheimer\u2019s disease fold","volume":"12","author":"Ghosh","year":"2024","journal-title":"Acta Neuropathologica Communications"},{"issue":"Pt 3","key":"10.1016\/bs.apcsb.2024.11.012_bib87","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1042\/bj3010871","article-title":"Epitope mapping of monoclonal antibodies to the paired helical filaments of Alzheimer\u2019s disease: Identification of phosphorylation sites in tau protein","volume":"301","author":"Goedert","year":"1994","journal-title":"The Biochemical Journal"},{"issue":"4","key":"10.1016\/bs.apcsb.2024.11.012_bib88","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/0896-6273(89)90210-9","article-title":"Multiple isoforms of human microtubule-associated protein tau: Sequences and localization in neurofibrillary tangles of Alzheimer\u2019s disease","volume":"3","author":"Goedert","year":"1989","journal-title":"Neuron"},{"issue":"2","key":"10.1016\/bs.apcsb.2024.11.012_bib89","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.ymthe.2020.10.007","article-title":"Anti-tau scFvs targeted to the cytoplasm or secretory pathway variably modify pathology and neurodegenerative phenotypes","volume":"29","author":"Goodwin","year":"2021","journal-title":"Molecular Therapy: The Journal of the American Society of Gene Therapy"},{"issue":"1","key":"10.1016\/bs.apcsb.2024.11.012_bib90","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/S0021-9258(18)48531-6","article-title":"Hydrofluoric acid-treated tau PHF proteins display the same biochemical properties as normal tau","volume":"267","author":"Greenberg","year":"1992","journal-title":"The Journal of Biological Chemistry"},{"issue":"4","key":"10.1016\/bs.apcsb.2024.11.012_bib91","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s00401-013-1080-2","article-title":"Argyrophilic grain disease differs from other tauopathies by lacking tau acetylation","volume":"125","author":"Grinberg","year":"2013","journal-title":"Acta Neuropathologica"},{"issue":"13","key":"10.1016\/bs.apcsb.2024.11.012_bib92","doi-asserted-by":"crossref","first-page":"4913","DOI":"10.1073\/pnas.83.13.4913","article-title":"Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology","volume":"83","author":"Grundke-Iqbal","year":"1986","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"16","key":"10.1016\/bs.apcsb.2024.11.012_bib93","doi-asserted-by":"crossref","first-page":"12556","DOI":"10.3390\/ijms241612556","article-title":"Blood-based biomarkers in the diagnosis of chronic traumatic encephalopathy: research to date and future directions","volume":"24","author":"Halicki","year":"2023","journal-title":"International Journal of Molecular Sciences"},{"issue":"14","key":"10.1016\/bs.apcsb.2024.11.012_bib94","doi-asserted-by":"crossref","first-page":"7475","DOI":"10.3390\/ijms22147475","article-title":"Autophagy and tau protein","volume":"22","author":"Hamano","year":"2021","journal-title":"International Journal of Molecular Sciences"},{"issue":"6","key":"10.1016\/bs.apcsb.2024.11.012_bib95","doi-asserted-by":"crossref","first-page":"922","DOI":"10.4088\/JCP.08m04606","article-title":"Lithium trial in Alzheimer\u2019s disease: A randomized, single-blind, placebo-controlled, multicenter 10-week study","volume":"70","author":"Hampel","year":"2009","journal-title":"The Journal of Clinical Psychiatry"},{"issue":"3","key":"10.1016\/bs.apcsb.2024.11.012_bib96","doi-asserted-by":"crossref","first-page":"615","DOI":"10.3233\/JAD-190197","article-title":"Lithium as a treatment for Alzheimer\u2019s disease: The systems pharmacology perspective","volume":"69","author":"Hampel","year":"2019","journal-title":"Journal of Alzheimer\u2019s Disease: JAD"},{"issue":"3","key":"10.1016\/bs.apcsb.2024.11.012_bib97","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.molmed.2009.01.003","article-title":"Tau phosphorylation: The therapeutic challenge for neurodegenerative disease","volume":"15","author":"Hanger","year":"2009","journal-title":"Trends in Molecular Medicine"},{"issue":"32","key":"10.1016\/bs.apcsb.2024.11.012_bib98","doi-asserted-by":"crossref","first-page":"23645","DOI":"10.1074\/jbc.M703269200","article-title":"Novel phosphorylation sites in tau from Alzheimer brain support a role for casein kinase 1 in disease pathogenesis","volume":"282","author":"Hanger","year":"2007","journal-title":"The Journal of Biological Chemistry"},{"issue":"1","key":"10.1016\/bs.apcsb.2024.11.012_bib99","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/0304-3940(92)90774-2","article-title":"Glycogen synthase kinase-3 induces Alzheimer\u2019s disease-like phosphorylation of tau: Generation of paired helical filament epitopes and neuronal localisation of the kinase","volume":"147","author":"Hanger","year":"1992","journal-title":"Neuroscience Letters"},{"issue":"2","key":"10.1016\/bs.apcsb.2024.11.012_bib100","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/0304-3940(90)90829-X","article-title":"Constant neurofibrillary changes in the neocortex in progressive supranuclear palsy. Basic differences with Alzheimer\u2019s disease and aging","volume":"119","author":"Hauw","year":"1990","journal-title":"Neuroscience Letters"},{"key":"10.1016\/bs.apcsb.2024.11.012_bib101","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1146\/annurev.biochem.67.1.425","article-title":"The ubiquitin system","volume":"67","author":"Hershko","year":"1998","journal-title":"Annual Review of Biochemistry"},{"issue":"2","key":"10.1016\/bs.apcsb.2024.11.012_bib102","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/BF00296179","article-title":"Quantitative neuropathologic analysis of Pick\u2019s disease cases: Cortical distribution of Pick bodies and coexistence with Alzheimer\u2019s disease","volume":"87","author":"Hof","year":"1994","journal-title":"Acta Neuropathologica"},{"issue":"1","key":"10.1016\/bs.apcsb.2024.11.012_bib103","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/BF00427214","article-title":"Distribution of cortical neurofibrillary tangles in progressive supranuclear palsy: A quantitative analysis of six cases","volume":"84","author":"Hof","year":"1992","journal-title":"Acta Neuropathologica"},{"issue":"4","key":"10.1016\/bs.apcsb.2024.11.012_bib104","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/mds.25815","article-title":"Tideglusib reduces progression of brain atrophy in progressive supranuclear palsy in a randomized trial","volume":"29","author":"H\u00f6glinger","year":"2014","journal-title":"Movement Disorders: Official Journal of the Movement Disorder Society"},{"issue":"1","key":"10.1016\/bs.apcsb.2024.11.012_bib105","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s40478-020-01019-z","article-title":"Regional correlation of biochemical measures of amyloid and tau phosphorylation in the brain","volume":"8","author":"Horie","year":"2020","journal-title":"Acta Neuropathologica Communications"},{"issue":"3\u20134","key":"10.1016\/bs.apcsb.2024.11.012_bib106","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.brainresbull.2011.03.006","article-title":"Valproate reduces tau phosphorylation via cyclin-dependent kinase 5 and glycogen synthase kinase 3 signaling pathways","volume":"85","author":"Hu","year":"2011","journal-title":"Brain Research Bulletin"},{"issue":"5","key":"10.1016\/bs.apcsb.2024.11.012_bib107","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1093\/emboj\/17.5.1371","article-title":"Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3beta and beta-catenin and promotes GSK-3beta-dependent phosphorylation of beta-catenin","volume":"17","author":"Ikeda","year":"1998","journal-title":"The EMBO Journal"},{"issue":"2","key":"10.1016\/bs.apcsb.2024.11.012_bib108","first-page":"179","article-title":"Physiology and pathology of tau protein kinases in relation to Alzheimer\u2019s disease","volume":"121","author":"Imahori","year":"1997","journal-title":"Journal of Biochemistry"},{"key":"10.1016\/bs.apcsb.2024.11.012_bib109","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2024.1375302","article-title":"Plasma GFAP, NfL and pTau 181 detect preclinical stages of dementia","volume":"15","author":"Ingannato","year":"2024","journal-title":"Frontiers in Endocrinology"},{"issue":"6314","key":"10.1016\/bs.apcsb.2024.11.012_bib110","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1126\/science.aah6205","article-title":"Site-specific phosphorylation of tau inhibits amyloid-\u03b2 toxicity in Alzheimer\u2019s mice","volume":"354","author":"Ittner","year":"2016","journal-title":"Science (New York, N. Y.)"},{"issue":"3","key":"10.1016\/bs.apcsb.2024.11.012_bib111","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.cell.2010.06.036","article-title":"Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer\u2019s disease mouse models","volume":"142","author":"Ittner","year":"2010","journal-title":"Cell"},{"issue":"1","key":"10.1016\/bs.apcsb.2024.11.012_bib112","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s40478-019-0664-z","article-title":"A walk through tau therapeutic strategies","volume":"7","author":"Jadhav","year":"2019","journal-title":"Acta Neuropathologica Communications"},{"issue":"22","key":"10.1016\/bs.apcsb.2024.11.012_bib113","doi-asserted-by":"crossref","first-page":"3541","DOI":"10.1091\/mbc.e14-06-1099","article-title":"Single-molecule tracking of tau reveals fast kiss-and-hop interaction with microtubules in living neurons","volume":"25","author":"Janning","year":"2014","journal-title":"Molecular Biology of the Cell"},{"issue":"6","key":"10.1016\/bs.apcsb.2024.11.012_bib114","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1083\/jcb.200301147","article-title":"Dynamic instability of microtubules is regulated by force","volume":"161","author":"Janson","year":"2003","journal-title":"The Journal of Cell Biology"},{"issue":"12","key":"10.1016\/bs.apcsb.2024.11.012_bib115","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1097\/NEN.0000000000000013","article-title":"Proteolytic cleavage of polymeric tau protein by caspase-3: Implications for Alzheimer disease","volume":"72","author":"Jarero-Basulto","year":"2013","journal-title":"Journal of Neuropathology and Experimental Neurology"},{"issue":"7","key":"10.1016\/bs.apcsb.2024.11.012_bib116","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1021\/bi0521543","article-title":"Global hairpin folding of tau in solution","volume":"45","author":"Jeganathan","year":"2006","journal-title":"Biochemistry"},{"key":"10.1016\/bs.apcsb.2024.11.012_bib117","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2020.586731","article-title":"Degradation and transmission of tau by autophagic-endolysosomal networks and potential therapeutic targets for tauopathy","volume":"13","author":"Jiang","year":"2020","journal-title":"Frontiers in Molecular Neuroscience"},{"issue":"5","key":"10.1016\/bs.apcsb.2024.11.012_bib118","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1046\/j.1471-4159.1997.69052087.x","article-title":"A conformation- and phosphorylation-dependent antibody recognizing the paired helical filaments of Alzheimer\u2019s disease","volume":"69","author":"Jicha","year":"1997","journal-title":"Journal of Neurochemistry"},{"issue":"1","key":"10.1016\/bs.apcsb.2024.11.012_bib119","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s40478-022-01436-2","article-title":"Tau seeding activity in various regions of down syndrome brain assessed by two novel assays","volume":"10","author":"Jin","year":"2022","journal-title":"Acta Neuropathologica Communications"},{"issue":"4","key":"10.1016\/bs.apcsb.2024.11.012_bib120","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1096\/fj.12-220889","article-title":"Imbalance of Hsp70 family variants fosters tau accumulation","volume":"27","author":"Jinwal","year":"2013","journal-title":"FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology"},{"issue":"39","key":"10.1016\/bs.apcsb.2024.11.012_bib121","doi-asserted-by":"crossref","first-page":"12079","DOI":"10.1523\/JNEUROSCI.3345-09.2009","article-title":"Chemical manipulation of hsp70 ATPase activity regulates tau stability","volume":"29","author":"Jinwal","year":"2009","journal-title":"The Journal of Neuroscience: The Official Journal of the Society for Neuroscience"},{"issue":"22","key":"10.1016\/bs.apcsb.2024.11.012_bib122","doi-asserted-by":"crossref","first-page":"16798","DOI":"10.1074\/jbc.M110.113753","article-title":"Hsc70 rapidly engages tau after microtubule destabilization","volume":"285","author":"Jinwal","year":"2010","journal-title":"The Journal of Biological Chemistry"},{"issue":"7","key":"10.1016\/bs.apcsb.2024.11.012_bib123","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1091\/mbc.E19-02-0101","article-title":"Behaviors of individual microtubules and microtubule populations relative to critical concentrations: Dynamic instability occurs when critical concentrations are driven apart by nucleotide hydrolysis","volume":"31","author":"Jonasson","year":"2020","journal-title":"Molecular Biology of the Cell"},{"issue":"7465","key":"10.1016\/bs.apcsb.2024.11.012_bib124","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nature12481","article-title":"Self-propagation of pathogenic protein aggregates in neurodegenerative diseases","volume":"501","author":"Jucker","year":"2013","journal-title":"Nature"},{"issue":"1","key":"10.1016\/bs.apcsb.2024.11.012_bib125","doi-asserted-by":"crossref","first-page":"24","DOI":"10.2174\/0115672050301407240408033046","article-title":"Post-translational modifications in tau and their roles in Alzheimer\u2019s pathology","volume":"21","author":"Kalyaanamoorthy","year":"2024","journal-title":"Current Alzheimer Research"},{"issue":"5","key":"10.1016\/bs.apcsb.2024.11.012_bib126","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S1474-4422(20)30071-5","article-title":"Blood phosphorylated tau 181 as a biomarker for Alzheimer\u2019s disease: A diagnostic performance and prediction modelling study using data from four prospective cohorts","volume":"19","author":"Karikari","year":"2020","journal-title":"The Lancet. Neurology"},{"issue":"6","key":"10.1016\/bs.apcsb.2024.11.012_bib127","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/s41580-018-0001-6","article-title":"The coming of age of chaperone-mediated autophagy","volume":"19","author":"Kaushik","year":"2018","journal-title":"Nature Reviews. Molecular Cell Biology"},{"issue":"6394","key":"10.1016\/bs.apcsb.2024.11.012_bib128","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1126\/science.aat1780","article-title":"Near-atomic model of microtubule-tau interactions","volume":"360","author":"Kellogg","year":"2018","journal-title":"Science (New York, N. Y.)"},{"issue":"2","key":"10.1016\/bs.apcsb.2024.11.012_bib129","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1111\/j.1471-4159.1992.tb09432.x","article-title":"Brain levels of microtubule-associated protein tau are elevated in Alzheimer\u2019s disease: A radioimmuno-slot-blot assay for nanograms of the protein","volume":"59","author":"Khatoon","year":"1992","journal-title":"Journal of Neurochemistry"},{"issue":"1","key":"10.1016\/bs.apcsb.2024.11.012_bib130","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/0014-5793(94)00829-9","article-title":"Levels of normal and abnormally phosphorylated tau in different cellular and regional compartments of Alzheimer disease and control brains","volume":"351","author":"Khatoon","year":"1994","journal-title":"FEBS Letters"},{"issue":"6","key":"10.1016\/bs.apcsb.2024.11.012_bib131","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1016\/j.neurobiolaging.2015.03.002","article-title":"Human tau expression reduces adult neurogenesis in a mouse model of tauopathy","volume":"36","author":"Komuro","year":"2015","journal-title":"Neurobiology of Aging"},{"issue":"7561","key":"10.1016\/bs.apcsb.2024.11.012_bib132","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/nature14658","article-title":"Antibody against early driver of neurodegeneration cis P-tau blocks brain injury and tauopathy","volume":"523","author":"Kondo","year":"2015","journal-title":"Nature"},{"issue":"1","key":"10.1016\/bs.apcsb.2024.11.012_bib133","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00401-007-0322-6","article-title":"MAPT S305I mutation: Implications for argyrophilic grain disease","volume":"116","author":"Kovacs","year":"2008","journal-title":"Acta Neuropathologica"},{"issue":"12","key":"10.1016\/bs.apcsb.2024.11.012_bib134","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.113529","article-title":"Molecular determinants of the crosstalk between endosomal microautophagy and chaperone-mediated autophagy","volume":"42","author":"Krause","year":"2023","journal-title":"Cell Reports"},{"issue":"6","key":"10.1016\/bs.apcsb.2024.11.012_bib135","first-page":"1496","article-title":"Ultrastructure and biochemical composition of paired helical filaments in corticobasal degeneration","volume":"145","author":"Ksiezak-Reding","year":"1994","journal-title":"The American Journal of Pathology"},{"key":"10.1016\/bs.apcsb.2024.11.012_bib136","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.782434","article-title":"Rapamycin attenuated zinc-induced tau phosphorylation and oxidative stress in rats: Involvement of dual mTOR\/p70S6K and Nrf2\/HO-1 pathways","volume":"13","author":"Lai","year":"2022","journal-title":"Frontiers in Immunology"},{"issue":"5","key":"10.1016\/bs.apcsb.2024.11.012_bib137","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2020.118664","article-title":"Glycogen synthase kinase-3 signaling in Alzheimer\u2019s disease","volume":"1867","author":"Lauretti","year":"2020","journal-title":"Biochimica et Biophysica Acta. Molecular Cell Research"},{"issue":"4","key":"10.1016\/bs.apcsb.2024.11.012_bib138","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1046\/j.1471-4159.1995.65041658.x","article-title":"Tau protein from Alzheimer\u2019s disease patients is glycated at its tubulin-binding domain","volume":"65","author":"Ledesma","year":"1995","journal-title":"Journal of Neurochemistry"},{"issue":"34","key":"10.1016\/bs.apcsb.2024.11.012_bib139","doi-asserted-by":"crossref","first-page":"21614","DOI":"10.1016\/S0021-9258(17)31849-5","article-title":"Analysis of microtubule-associated protein tau glycation in paired helical filaments","volume":"269","author":"Ledesma","year":"1994","journal-title":"The Journal of Biological Chemistry"},{"issue":"4994","key":"10.1016\/bs.apcsb.2024.11.012_bib140","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1126\/science.1899488","article-title":"A68: A major subunit of paired helical filaments and derivatized forms of normal Tau","volume":"251","author":"Lee","year":"1991","journal-title":"Science (New York, N. Y.)"},{"issue":"7312","key":"10.1016\/bs.apcsb.2024.11.012_bib141","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nature09299","article-title":"Enhancement of proteasome activity by a small-molecule inhibitor of USP14","volume":"467","author":"Lee","year":"2010","journal-title":"Nature"},{"issue":"Pt 2","key":"10.1016\/bs.apcsb.2024.11.012_bib142","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1242\/jcs.102.2.227","article-title":"Expression of tau protein in non-neuronal cells: Microtubule binding and stabilization","volume":"102","author":"Lee","year":"1992","journal-title":"Journal of Cell Science"},{"issue":"2","key":"10.1016\/bs.apcsb.2024.11.012_bib143","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s004010100435","article-title":"The active form of glycogen synthase kinase-3beta is associated with granulovacuolar degeneration in neurons in Alzheimer\u2019s disease","volume":"103","author":"Leroy","year":"2002","journal-title":"Acta Neuropathologica"},{"issue":"25","key":"10.1016\/bs.apcsb.2024.11.012_bib144","doi-asserted-by":"crossref","first-page":"19125","DOI":"10.1074\/jbc.M110.105387","article-title":"Tau potentiates nerve growth factor-induced mitogen-activated protein kinase signaling and neurite initiation without a requirement for microtubule binding","volume":"285","author":"Leugers","year":"2010","journal-title":"The Journal of Biological Chemistry"},{"issue":"9","key":"10.1016\/bs.apcsb.2024.11.012_bib145","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1073\/pnas.1418155112","article-title":"Regulation and aggregation of intrinsically disordered peptides","volume":"112","author":"Levine","year":"2015","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"2","key":"10.1016\/bs.apcsb.2024.11.012_bib146","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s40120-019-00164-5","article-title":"An update on blood-based markers of Alzheimer\u2019s disease using the SiMoA platform","volume":"8","author":"Li","year":"2019","journal-title":"Neurology and Therapy"},{"issue":"4","key":"10.1016\/bs.apcsb.2024.11.012_bib147","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/00019052-199708000-00011","article-title":"The clinical and pathologic hallmarks of progressive supranuclear palsy","volume":"10","author":"Litvan","year":"1997","journal-title":"Current Opinion in Neurology"},{"issue":"8","key":"10.1016\/bs.apcsb.2024.11.012_bib148","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1111\/j.1460-9568.2005.04391.x","article-title":"Contributions of protein phosphatases PP1, PP2A, PP2B and PP5 to the regulation of tau phosphorylation","volume":"22","author":"Liu","year":"2005","journal-title":"The European Journal of Neuroscience"},{"issue":"3","key":"10.1016\/bs.apcsb.2024.11.012_bib149","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1074\/jbc.M410775200","article-title":"Dephosphorylation of tau by protein phosphatase 5: Impairment in Alzheimer\u2019s disease","volume":"280","author":"Liu","year":"2005","journal-title":"The Journal of Biological Chemistry"},{"issue":"12","key":"10.1016\/bs.apcsb.2024.11.012_bib150","doi-asserted-by":"crossref","first-page":"3429","DOI":"10.1111\/j.1460-9568.2007.05955.x","article-title":"Site-specific effects of tau phosphorylation on its microtubule assembly activity and self-aggregation","volume":"26","author":"Liu","year":"2007","journal-title":"The European Journal of Neuroscience"},{"key":"10.1016\/bs.apcsb.2024.11.012_bib151","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.1022821","article-title":"The emerging role of autophagy and mitophagy in tauopathies: From pathogenesis to translational implications in Alzheimer\u2019s disease","volume":"14","author":"Liu","year":"2022","journal-title":"Frontiers in Aging Neuroscience"},{"issue":"11","key":"10.1016\/bs.apcsb.2024.11.012_bib152","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/cns.12445","article-title":"Valproic acid modifies synaptic structure and accelerates neurite outgrowth via the glycogen synthase kinase-3\u03b2 signaling pathway in an Alzheimer\u2019s disease model","volume":"21","author":"Long","year":"2015","journal-title":"CNS Neuroscience & Therapeutics"},{"issue":"3","key":"10.1016\/bs.apcsb.2024.11.012_bib153","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/s41582-018-0132-6","article-title":"Dementia in Down syndrome: Unique insights for Alzheimer disease research","volume":"15","author":"Lott","year":"2019","journal-title":"Nature Reviews. Neurology"},{"issue":"1","key":"10.1016\/bs.apcsb.2024.11.012_bib154","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3233\/JAD-141959","article-title":"A phase II trial of tideglusib in Alzheimer\u2019s disease","volume":"45","author":"Lovestone","year":"2015","journal-title":"Journal of Alzheimer\u2019s Disease: JAD"},{"issue":"22","key":"10.1016\/bs.apcsb.2024.11.012_bib155","doi-asserted-by":"crossref","first-page":"9511","DOI":"10.1073\/pnas.0701055104","article-title":"Roles of heat-shock protein 90 in maintaining and facilitating the neurodegenerative phenotype in tauopathies","volume":"104","author":"Luo","year":"2007","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"46","key":"10.1016\/bs.apcsb.2024.11.012_bib156","doi-asserted-by":"crossref","first-page":"16586","DOI":"10.1073\/pnas.1417548111","article-title":"SUMOylation at K340 inhibits tau degradation through deregulating its phosphorylation and ubiquitination","volume":"111","author":"Luo","year":"2014","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"7","key":"10.1016\/bs.apcsb.2024.11.012_bib157","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1002\/gps.1964","article-title":"A feasibility and tolerability study of lithium in Alzheimer\u2019s disease","volume":"23","author":"Macdonald","year":"2008","journal-title":"International Journal of Geriatric Psychiatry"},{"issue":"3","key":"10.1016\/bs.apcsb.2024.11.012_bib158","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0014-5793(98)00910-7","article-title":"Phosphorylation of specific sets of tau isoforms reflects different neurofibrillary degeneration processes","volume":"433","author":"Mailliot","year":"1998","journal-title":"FEBS Letters"},{"issue":"2","key":"10.1016\/bs.apcsb.2024.11.012_bib159","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0047-6374(88)90041-3","article-title":"The pathological association between Down syndrome and Alzheimer disease","volume":"43","author":"Mann","year":"1988","journal-title":"Mechanisms of Ageing and Development"},{"issue":"1","key":"10.1016\/bs.apcsb.2024.11.012_bib160","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s40478-017-0482-0","article-title":"Lessons learned about [F-18]-AV-1451 off-target binding from an autopsy-confirmed Parkinson\u2019s case","volume":"5","author":"Marqui\u00e9","year":"2017","journal-title":"Acta Neuropathologica Communications"},{"issue":"4","key":"10.1016\/bs.apcsb.2024.11.012_bib161","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.neuint.2010.12.023","article-title":"Post-translational modifications of tau protein: Implications for Alzheimer\u2019s disease","volume":"58","author":"Martin","year":"2011","journal-title":"Neurochemistry International"},{"issue":"2","key":"10.1016\/bs.apcsb.2024.11.012_bib162","doi-asserted-by":"crossref","first-page":"403","DOI":"10.3233\/JAD-150437","article-title":"Lithium as a treatment for Alzheimer\u2019s disease: A systematic review and meta-analysis","volume":"48","author":"Matsunaga","year":"2015","journal-title":"Journal of Alzheimer\u2019s Disease: JAD"},{"issue":"12","key":"10.1016\/bs.apcsb.2024.11.012_bib163","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.105623","article-title":"KIBRA regulates activity-induced AMPA receptor expression and synaptic plasticity in an age-dependent manner","volume":"25","author":"Mendoza","year":"2022","journal-title":"iScience"},{"issue":"3","key":"10.1016\/bs.apcsb.2024.11.012_bib164","doi-asserted-by":"crossref","first-page":"4671","DOI":"10.3390\/ijms15034671","article-title":"Tau protein modifications and interactions: Their role in function and dysfunction","volume":"15","author":"Mietelska-Porowska","year":"2014","journal-title":"International Journal of Molecular Sciences"},{"issue":"6","key":"10.1016\/bs.apcsb.2024.11.012_bib165","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.neuron.2010.08.044","article-title":"Acetylation of tau inhibits its degradation and contributes to tauopathy","volume":"67","author":"Min","year":"2010","journal-title":"Neuron"},{"issue":"9","key":"10.1016\/bs.apcsb.2024.11.012_bib166","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/0896-6273(88)90124-9","article-title":"Cytoskeletal dynamics and nerve growth","volume":"1","author":"Mitchison","year":"1988","journal-title":"Neuron"},{"issue":"2","key":"10.1016\/bs.apcsb.2024.11.012_bib167","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/S0006-291X(86)80242-X","article-title":"Self assembly of microtubule associated protein tau into filaments resembling those found in Alzheimer disease","volume":"141","author":"Montejo de Garcini","year":"1986","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"8","key":"10.1016\/bs.apcsb.2024.11.012_bib168","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1038\/nn.4067","article-title":"Tau post-translational modifications in wild-type and human amyloid precursor protein transgenic mice","volume":"18","author":"Morris","year":"2015","journal-title":"Nature Neuroscience"},{"issue":"3","key":"10.1016\/bs.apcsb.2024.11.012_bib169","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.neuron.2011.04.009","article-title":"The many faces of tau","volume":"70","author":"Morris","year":"2011","journal-title":"Neuron"},{"issue":"2","key":"10.1016\/bs.apcsb.2024.11.012_bib170","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1515\/bmc.2010.017","article-title":"Tau and neurodegenerative disorders","volume":"1","author":"Motoi","year":"2010","journal-title":"Biomolecular Concepts"},{"key":"10.1016\/bs.apcsb.2024.11.012_bib171","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2021.647054","article-title":"Tau: A signaling hub protein","volume":"14","author":"Mueller","year":"2021","journal-title":"Frontiers in Molecular Neuroscience"},{"issue":"1","key":"10.1016\/bs.apcsb.2024.11.012_bib172","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nm.4011","article-title":"Tau-driven 26S proteasome impairment and cognitive dysfunction can be prevented early in disease by activating cAMP-PKA signaling","volume":"22","author":"Myeku","year":"2016","journal-title":"Nature Medicine"},{"issue":"5","key":"10.1016\/bs.apcsb.2024.11.012_bib173","first-page":"887","article-title":"Radioimmunoassays for Ig classes G, A, M, D, and E in spinal fluids: Normal values of different age groups","volume":"86","author":"Nerenberg","year":"1975","journal-title":"The Journal of Laboratory and Clinical Medicine"},{"issue":"4","key":"10.1016\/bs.apcsb.2024.11.012_bib174","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0896-6273(03)00259-9","article-title":"Cdk5 is a key factor in tau aggregation and tangle formation in vivo","volume":"38","author":"Noble","year":"2003","journal-title":"Neuron"},{"issue":"2","key":"10.1016\/bs.apcsb.2024.11.012_bib175","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S1474-4422(16)30331-3","article-title":"Safety and immunogenicity of the tau vaccine AADvac1 in patients with Alzheimer\u2019s disease: A randomised, double-blind, placebo-controlled, phase 1 trial","volume":"16","author":"Novak","year":"2017","journal-title":"The Lancet. Neurology"},{"issue":"1","key":"10.1016\/bs.apcsb.2024.11.012_bib176","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s13195-018-0436-1","article-title":"FUNDAMANT: An interventional 72-week phase 1 follow-up study of AADvac1, an active immunotherapy against tau protein pathology in Alzheimer\u2019s disease","volume":"10","author":"Novak","year":"2018","journal-title":"Alzheimer\u2019s Research & Therapy"},{"issue":"1","key":"10.1016\/bs.apcsb.2024.11.012_bib177","doi-asserted-by":"crossref","first-page":"63","DOI":"10.14283\/jpad.2018.45","article-title":"AADvac1, an active immunotherapy for Alzheimer\u2019s disease and non alzheimer tauopathies: An overview of preclinical and clinical development","volume":"6","author":"Novak","year":"2019","journal-title":"The Journal of Prevention of Alzheimer\u2019s Disease"},{"issue":"1","key":"10.1016\/bs.apcsb.2024.11.012_bib178","first-page":"104","article-title":"Microdose lithium treatment stabilized cognitive impairment in patients with Alzheimer\u2019s disease","volume":"10","author":"Nunes","year":"2013","journal-title":"Current Alzheimer Research"},{"key":"10.1016\/bs.apcsb.2024.11.012_bib179","article-title":"Clinical spectrum of tauopathies","volume":"13","author":"Olfati","year":"2022","journal-title":"Frontiers in Neurology"},{"issue":"7","key":"10.1016\/bs.apcsb.2024.11.012_bib180","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.tips.2017.03.011","article-title":"A brief overview of tauopathy: Causes, consequences, and therapeutic strategies","volume":"38","author":"Orr","year":"2017","journal-title":"Trends in Pharmacological Sciences"},{"key":"10.1016\/bs.apcsb.2024.11.012_bib181","doi-asserted-by":"crossref","DOI":"10.1177\/21501319221141178","article-title":"Alzheimer disease biomarkers in clinical practice: a blood-based diagnostic revolution","volume":"13","author":"Paczynski","year":"2022","journal-title":"Journal of Primary Care & Community Health"},{"issue":"8","key":"10.1016\/bs.apcsb.2024.11.012_bib182","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1001\/jama.2020.12134","article-title":"Discriminative accuracy of plasma phospho-tau217 for Alzheimer disease vs other neurodegenerative disorders","volume":"324","author":"Palmqvist","year":"2020","journal-title":"JAMA: The Journal of the American Medical Association"},{"issue":"4","key":"10.1016\/bs.apcsb.2024.11.012_bib183","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/ana.410380423","article-title":"Reversible dementia and apparent brain atrophy during valproate therapy","volume":"38","author":"Papazian","year":"1995","journal-title":"Annals of Neurology"},{"issue":"20","key":"10.1016\/bs.apcsb.2024.11.012_bib184","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1212\/WNL.0b013e318292a2e5","article-title":"Sodium valproate use is associated with reduced parietal lobe thickness and brain volume","volume":"80","author":"Pardoe","year":"2013","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/bs.apcsb.2024.11.012_bib185","first-page":"781","article-title":"18F-AV-1451 positron emission tomography in Alzheimer\u2019s disease and progressive supranuclear palsy","volume":"140","author":"Passamonti","year":"2017","journal-title":"Brain: A Journal of Neurology"},{"issue":"24","key":"10.1016\/bs.apcsb.2024.11.012_bib186","doi-asserted-by":"crossref","first-page":"6280","DOI":"10.3390\/cancers13246280","article-title":"HDAC6 inhibition extinguishes autophagy in cancer: Recent insights","volume":"13","author":"Passaro","year":"2021","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/bs.apcsb.2024.11.012_bib187","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/00005072-199701000-00007","article-title":"Distribution, levels, and activity of glycogen synthase kinase-3 in the Alzheimer disease brain","volume":"56","author":"Pei","year":"1997","journal-title":"Journal of Neuropathology and Experimental Neurology"},{"issue":"7","key":"10.1016\/bs.apcsb.2024.11.012_bib188","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1093\/hmg\/ddh083","article-title":"CHIP and Hsp70 regulate tau ubiquitination, degradation and aggregation","volume":"13","author":"Petrucelli","year":"2004","journal-title":"Human Molecular Genetics"},{"key":"10.1016\/bs.apcsb.2024.11.012_bib189","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.105010","article-title":"Passive immunotherapies targeting A\u03b2 and tau in Alzheimer\u2019s disease","volume":"144","author":"Plotkin","year":"2020","journal-title":"Neurobiology of Disease"},{"issue":"4","key":"10.1016\/bs.apcsb.2024.11.012_bib190","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/embor.2013.15","article-title":"Physiological release of endogenous tau is stimulated by neuronal activity","volume":"14","author":"Pooler","year":"2013","journal-title":"EMBO Reports"},{"issue":"12","key":"10.1016\/bs.apcsb.2024.11.012_bib191","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1084\/jem.20081588","article-title":"Valproic acid inhibits Abeta production, neuritic plaque formation, and behavioral deficits in Alzheimer\u2019s disease mouse models","volume":"205","author":"Qing","year":"2008","journal-title":"The Journal of Experimental Medicine"},{"key":"10.1016\/bs.apcsb.2024.11.012_bib192","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.trci.2018.10.007","article-title":"A randomized, single ascending dose study of intravenous BIIB092 in healthy participants","volume":"4","author":"Qureshi","year":"2018","journal-title":"Alzheimer\u2019s & Dementia (New York, N. Y.)"},{"issue":"5","key":"10.1016\/bs.apcsb.2024.11.012_bib193","doi-asserted-by":"crossref","first-page":"375","DOI":"10.2165\/11533100-000000000-00000","article-title":"Frontotemporal lobar degeneration: Epidemiology, pathophysiology, diagnosis and management","volume":"24","author":"Rabinovici","year":"2010","journal-title":"CNS Drugs"},{"issue":"21","key":"10.1016\/bs.apcsb.2024.11.012_bib194","doi-asserted-by":"crossref","first-page":"12841","DOI":"10.3390\/ijms232112841","article-title":"Phosphorylated tau in Alzheimer\u2019s disease and other tauopathies","volume":"23","author":"Rawat","year":"2022","journal-title":"International Journal of Molecular Sciences"},{"issue":"1","key":"10.1016\/bs.apcsb.2024.11.012_bib195","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1001\/archneur.1968.00470310034003","article-title":"Corticodentatonigral degeneration with neuronal achromasia","volume":"18","author":"Rebeiz","year":"1968","journal-title":"Archives of Neurology"},{"issue":"1","key":"10.1016\/bs.apcsb.2024.11.012_bib196","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00401-011-0898-8","article-title":"Selective tau tyrosine nitration in non-AD tauopathies","volume":"123","author":"Reyes","year":"2012","journal-title":"Acta Neuropathologica"},{"issue":"Pt 5","key":"10.1016\/bs.apcsb.2024.11.012_bib197","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1093\/brain\/117.5.1183","article-title":"Corticobasal degeneration. A clinical study of 36 cases","volume":"117","author":"Rinne","year":"1994","journal-title":"Brain: A Journal of Neurology"},{"issue":"10","key":"10.1016\/bs.apcsb.2024.11.012_bib198","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/s41573-020-0075-7","article-title":"Advances in oligonucleotide drug delivery","volume":"19","author":"Roberts","year":"2020","journal-title":"Nature Reviews. Drug Discovery"},{"issue":"1","key":"10.1016\/bs.apcsb.2024.11.012_bib199","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1590\/S1980-57642015DN91000002","article-title":"Argyrophilic grain disease: An underestimated tauopathy","volume":"9","author":"Rodriguez","year":"2015","journal-title":"Dementia & Neuropsychologia"},{"issue":"7","key":"10.1016\/bs.apcsb.2024.11.012_bib200","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1093\/jnen\/nlw034","article-title":"Argyrophilic grain disease: Demographics, clinical, and neuropathological features from a large autopsy study","volume":"75","author":"Rodriguez","year":"2016","journal-title":"Journal of Neuropathology and Experimental Neurology"},{"issue":"2","key":"10.1016\/bs.apcsb.2024.11.012_bib201","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s00401-013-1229-z","article-title":"Neuropathological characterization of two siblings carrying the MAPT S305S mutation demonstrates features resembling argyrophilic grain disease","volume":"127","author":"R\u00f6nnb\u00e4ck","year":"2014","journal-title":"Acta Neuropathologica"},{"key":"10.1016\/bs.apcsb.2024.11.012_bib202","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.trci.2018.09.005","article-title":"Highly specific and selective anti-pS396-tau antibody C10.2 targets seeding-competent tau","volume":"4","author":"Rosenqvist","year":"2018","journal-title":"Alzheimer\u2019s & Dementia (New York, N. Y.)"},{"issue":"1","key":"10.1016\/bs.apcsb.2024.11.012_bib203","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3233\/JAD-160633","article-title":"Comprehensive quantitative profiling of tau and phosphorylated tau peptides in cerebrospinal fluid by mass spectrometry provides new biomarker candidates","volume":"55","author":"Russell","year":"2017","journal-title":"Journal of Alzheimer\u2019s Disease: JAD"},{"issue":"12","key":"10.1016\/bs.apcsb.2024.11.012_bib204","doi-asserted-by":"crossref","DOI":"10.1172\/JCI168553","article-title":"Tau pathology in neurodegenerative disease: Disease mechanisms and therapeutic avenues","volume":"133","author":"Samudra","year":"2023","journal-title":"The Journal of Clinical Investigation"},{"issue":"5","key":"10.1016\/bs.apcsb.2024.11.012_bib205","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0125614","article-title":"Passive immunization with phospho-tau antibodies reduces tau pathology and functional deficits in two distinct mouse tauopathy models","volume":"10","author":"Sankaranarayanan","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/bs.apcsb.2024.11.012_bib206","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.ejmech.2017.11.103","article-title":"Glycogen synthase kinase-3 and its inhibitors: Potential target for various therapeutic conditions","volume":"144","author":"Saraswati","year":"2018","journal-title":"European Journal of Medicinal Chemistry"},{"issue":"12","key":"10.1016\/bs.apcsb.2024.11.012_bib207","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1002\/jnr.21721","article-title":"Two motifs within the tau microtubule-binding domain mediate its association with the hsc70 molecular chaperone","volume":"86","author":"Sarkar","year":"2008","journal-title":"Journal of Neuroscience Research"},{"issue":"5","key":"10.1016\/bs.apcsb.2024.11.012_bib208","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1097\/00005072-199605000-00006","article-title":"Neurofibrillary tangles in progressive supranuclear palsy contain the same tau epitopes identified in Alzheimer\u2019s disease PHFtau","volume":"55","author":"Schmidt","year":"1996","journal-title":"Journal of Neuropathology and Experimental Neurology"},{"issue":"2","key":"10.1016\/bs.apcsb.2024.11.012_bib209","doi-asserted-by":"crossref","DOI":"10.1212\/NXG.0000000000000323","article-title":"Antisense oligonucleotides: A primer","volume":"5","author":"Scoles","year":"2019","journal-title":"Neurology. Genetics"},{"issue":"2","key":"10.1016\/bs.apcsb.2024.11.012_bib210","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/S0021-9258(18)54055-2","article-title":"Phosphorylation of recombinant tau by cAMP-dependent protein kinase. Identification of phosphorylation sites and effect on microtubule assembly","volume":"268","author":"Scott","year":"1993","journal-title":"The Journal of Biological Chemistry"},{"issue":"3","key":"10.1016\/bs.apcsb.2024.11.012_bib211","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.nbd.2009.05.025","article-title":"A novel GSK-3beta inhibitor reduces Alzheimer\u2019s pathology and rescues neuronal loss in vivo","volume":"35","author":"Seren\u00f3","year":"2009","journal-title":"Neurobiology of Disease"},{"issue":"3","key":"10.1016\/bs.apcsb.2024.11.012_bib212","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1046\/j.1471-4159.1999.0721243.x","article-title":"Neurofibrillary degeneration in progressive supranuclear palsy and corticobasal degeneration: Tau pathologies with exclusively \"exon 10\" isoforms","volume":"72","author":"Sergeant","year":"1999","journal-title":"Journal of Neurochemistry"},{"issue":"5","key":"10.1016\/bs.apcsb.2024.11.012_bib213","doi-asserted-by":"crossref","first-page":"446","DOI":"10.2174\/156720509789207930","article-title":"Tau-focused immunotherapy for Alzheimer\u2019s disease and related tauopathies","volume":"6","author":"Sigurdsson","year":"2009","journal-title":"Current Alzheimer Research"},{"issue":"6","key":"10.1016\/bs.apcsb.2024.11.012_bib214","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1001\/jama.2023.13239","article-title":"Donanemab in early symptomatic Alzheimer disease: The TRAILBLAZER-ALZ 2 randomized clinical trial","volume":"330","author":"Sims","year":"2023","journal-title":"JAMA: The Journal of the American Medical Association"},{"issue":"5","key":"10.1016\/bs.apcsb.2024.11.012_bib215","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.4103\/1673-5374.385288","article-title":"New insights into the therapeutic approaches for the treatment of tauopathies","volume":"19","author":"Singh","year":"2024","journal-title":"Neural Regeneration Research"},{"issue":"2","key":"10.1016\/bs.apcsb.2024.11.012_bib216","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/j.1468-1331.2007.02017.x","article-title":"The tau S305S mutation causes frontotemporal dementia with parkinsonism","volume":"15","author":"Skoglund","year":"2008","journal-title":"European Journal of Neurology"},{"issue":"4","key":"10.1016\/bs.apcsb.2024.11.012_bib217","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/0166-2236(95)93897-7","article-title":"Radical AGEing in Alzheimer\u2019s disease","volume":"18","author":"Smith","year":"1995","journal-title":"Trends in Neurosciences"},{"issue":"1","key":"10.1016\/bs.apcsb.2024.11.012_bib218","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s13024-016-0109-0","article-title":"Acetylated tau destabilizes the cytoskeleton in the axon initial segment and is mislocalized to the somatodendritic compartment","volume":"11","author":"Sohn","year":"2016","journal-title":"Molecular Neurodegeneration"},{"key":"10.1016\/bs.apcsb.2024.11.012_bib219","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3389\/fnmol.2014.00016","article-title":"Protein phosphatase 2A dysfunction in Alzheimer\u2019s disease","volume":"7","author":"Sontag","year":"2014","journal-title":"Frontiers in Molecular Neuroscience"},{"key":"10.1016\/bs.apcsb.2024.11.012_bib220","first-page":"333","article-title":"Progressive supranuclear palsy: A heterogeneous degeneration involving the brain stem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia","volume":"10","author":"Steele","year":"1964","journal-title":"JAMA Neurology"},{"key":"10.1016\/bs.apcsb.2024.11.012_bib221","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/7263736","article-title":"HDAC6 regulates the chaperone-mediated autophagy to prevent oxidative damage in injured neurons after experimental spinal cord injury","volume":"2016","author":"Su","year":"2016","journal-title":"Oxidative Medicine and Cellular Longevity"},{"issue":"12","key":"10.1016\/bs.apcsb.2024.11.012_bib222","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202012921","article-title":"Novel tau biomarkers phosphorylated at T181, T217 or T231 rise in the initial stages of the preclinical Alzheimer\u2019s continuum when only subtle changes in A\u03b2 pathology are detected","volume":"12","author":"Su\u00e1rez-Calvet","year":"2020","journal-title":"EMBO Molecular Medicine"},{"issue":"6","key":"10.1016\/bs.apcsb.2024.11.012_bib223","doi-asserted-by":"crossref","first-page":"4566","DOI":"10.1074\/jbc.M110.199976","article-title":"Nuclear tau, a key player in neuronal DNA protection","volume":"286","author":"Sultan","year":"2011","journal-title":"The Journal of Biological Chemistry"},{"issue":"78","key":"10.1016\/bs.apcsb.2024.11.012_bib224","doi-asserted-by":"crossref","first-page":"10805","DOI":"10.1039\/D4CC03774J","article-title":"Recent advances in DNAzymes for bioimaging, biosensing and cancer therapy","volume":"60","author":"Sun","year":"2024","journal-title":"Chemical Communications (Cambridge, England)"},{"key":"10.1016\/bs.apcsb.2024.11.012_bib225","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.neulet.2017.05.056","article-title":"Microtubule-associated tau contributes to intra-dendritic trafficking of AMPA receptors in multiple ways","volume":"653","author":"Suzuki","year":"2017","journal-title":"Neuroscience Letters"},{"issue":"4","key":"10.1016\/bs.apcsb.2024.11.012_bib226","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1016\/j.ajpath.2012.06.033","article-title":"The synaptic accumulation of hyperphosphorylated tau oligomers in Alzheimer disease is associated with dysfunction of the ubiquitin-proteasome system","volume":"181","author":"Tai","year":"2012","journal-title":"The American Journal of Pathology"},{"issue":"9","key":"10.1016\/bs.apcsb.2024.11.012_bib227","doi-asserted-by":"crossref","first-page":"7614","DOI":"10.1074\/jbc.M408714200","article-title":"Inhibition of heparin-induced tau filament formation by phenothiazines, polyphenols, and porphyrins","volume":"280","author":"Taniguchi","year":"2005","journal-title":"The Journal of Biological Chemistry"},{"issue":"8","key":"10.1016\/bs.apcsb.2024.11.012_bib228","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1001\/archgenpsychiatry.2011.72","article-title":"Chronic divalproex sodium to attenuate agitation and clinical progression of Alzheimer disease","volume":"68","author":"Tariot","year":"2011","journal-title":"Archives of General Psychiatry"},{"issue":"8","key":"10.1016\/bs.apcsb.2024.11.012_bib229","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0072301","article-title":"Efficacy and safety of a liposome-based vaccine against protein Tau, assessed in tau.P301L mice that model tauopathy","volume":"8","author":"Theunis","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/bs.apcsb.2024.11.012_bib230","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1007\/s00259-021-05673-w","article-title":"International consensus on the use of tau PET imaging agent 18F-flortaucipir in Alzheimer\u2019s disease","volume":"49","author":"Tian","year":"2022","journal-title":"European Journal of Nuclear Medicine and Molecular Imaging"},{"issue":"1","key":"10.1016\/bs.apcsb.2024.11.012_bib231","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s00401-002-0520-1","article-title":"Ballooned neurons in progressive supranuclear palsy are usually due to concurrent argyrophilic grain disease","volume":"104","author":"Togo","year":"2002","journal-title":"Acta Neuropathologica"},{"issue":"6","key":"10.1016\/bs.apcsb.2024.11.012_bib232","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1093\/jnen\/61.6.547","article-title":"Argyrophilic grain disease is a sporadic 4-repeat tauopathy","volume":"61","author":"Togo","year":"2002","journal-title":"Journal of Neuropathology and Experimental Neurology"},{"issue":"4","key":"10.1016\/bs.apcsb.2024.11.012_bib233","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1440-1789.2004.00591.x","article-title":"Argyrophilic grain disease: A late-onset dementia with distinctive features among tauopathies","volume":"24","author":"Tolnay","year":"2004","journal-title":"Neuropathology: Official Journal of the Japanese Society of Neuropathology"},{"issue":"4","key":"10.1016\/bs.apcsb.2024.11.012_bib234","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/mds.25824","article-title":"A phase 2 trial of the GSK-3 inhibitor tideglusib in progressive supranuclear palsy","volume":"29","author":"Tolosa","year":"2014","journal-title":"Movement Disorders: Official Journal of the Movement Disorder Society"},{"key":"10.1016\/bs.apcsb.2024.11.012_bib235","doi-asserted-by":"crossref","first-page":"256","DOI":"10.3389\/fnagi.2019.00256","article-title":"The evolution of tau phosphorylation and interactions","volume":"11","author":"Trushina","year":"2019","journal-title":"Frontiers in Aging Neuroscience"},{"issue":"1","key":"10.1016\/bs.apcsb.2024.11.012_bib236","doi-asserted-by":"crossref","first-page":"5522","DOI":"10.1038\/s41467-020-19317-4","article-title":"An HDAC6-dependent surveillance mechanism suppresses tau-mediated neurodegeneration and cognitive decline","volume":"11","author":"Trzeciakiewicz","year":"2020","journal-title":"Nature Communications"},{"issue":"1","key":"10.1016\/bs.apcsb.2024.11.012_bib237","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in early Alzheimer\u2019s disease","volume":"388","author":"van Dyck","year":"2023","journal-title":"The New England Journal of Medicine"},{"issue":"s1","key":"10.1016\/bs.apcsb.2024.11.012_bib238","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.3233\/JAD-230603","article-title":"Immunotherapy in Alzheimer\u2019s disease: Current status and future directions","volume":"101","author":"Vashisth","year":"2024","journal-title":"Journal of Alzheimer\u2019s Disease: JAD"},{"issue":"5","key":"10.1016\/bs.apcsb.2024.11.012_bib239","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/ana.410330506","article-title":"Dementia in Parkinson\u2019s disease: Biochemical evidence for cortical involvement using the immunodetection of abnormal Tau proteins","volume":"33","author":"Vermersch","year":"1993","journal-title":"Annals of Neurology"},{"issue":"1-2","key":"10.1016\/bs.apcsb.2024.11.012_bib240","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0304-3940(92)90736-Q","article-title":"Presence of abnormally phosphorylated Tau proteins in the entorhinal cortex of aged non-demented subjects","volume":"144","author":"Vermersch","year":"1992","journal-title":"Neuroscience Letters"},{"issue":"25","key":"10.1016\/bs.apcsb.2024.11.012_bib241","doi-asserted-by":"crossref","first-page":"14220","DOI":"10.1073\/pnas.2003277117","article-title":"cGMP via PKG activates 26S proteasomes and enhances degradation of proteins, including ones that cause neurodegenerative diseases","volume":"117","author":"VerPlank","year":"2020","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"10","key":"10.1016\/bs.apcsb.2024.11.012_bib242","doi-asserted-by":"crossref","first-page":"5129","DOI":"10.1073\/pnas.97.10.5129","article-title":"Assembly of tau protein into Alzheimer paired helical filaments depends on a local sequence motif ((306)VQIVYK(311)) forming beta structure","volume":"97","author":"von Bergen","year":"2000","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.apcsb.2024.11.012_bib243","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112915","article-title":"Small molecule therapeutics for tauopathy in Alzheimer\u2019s disease: Walking on the path of most resistance","volume":"209","author":"Wang","year":"2021","journal-title":"European Journal of Medicinal Chemistry"},{"issue":"11","key":"10.1016\/bs.apcsb.2024.11.012_bib244","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1523\/JNEUROSCI.5077-10.2011","article-title":"Robust amyloid clearance in a mouse model of Alzheimer\u2019s disease provides novel insights into the mechanism of amyloid-beta immunotherapy","volume":"31","author":"Wang","year":"2011","journal-title":"The Journal of Neuroscience: The Official Journal of the Society for Neuroscience"},{"issue":"8","key":"10.1016\/bs.apcsb.2024.11.012_bib245","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/nm0896-871","article-title":"Glycosylation of microtubule-associated protein tau: An abnormal posttranslational modification in Alzheimer\u2019s disease","volume":"2","author":"Wang","year":"1996","journal-title":"Nature Medicine"},{"issue":"52","key":"10.1016\/bs.apcsb.2024.11.012_bib246","doi-asserted-by":"crossref","first-page":"15120","DOI":"10.1073\/pnas.1606899113","article-title":"Loss of O-GlcNAc glycosylation in forebrain excitatory neurons induces neurodegeneration","volume":"113","author":"Wang","year":"2016","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"21","key":"10.1016\/bs.apcsb.2024.11.012_bib247","doi-asserted-by":"crossref","first-page":"4153","DOI":"10.1093\/hmg\/ddp367","article-title":"Tau fragmentation, aggregation and clearance: The dual role of lysosomal processing","volume":"18","author":"Wang","year":"2009","journal-title":"Human Molecular Genetics"},{"issue":"4","key":"10.1016\/bs.apcsb.2024.11.012_bib248","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/s41557-021-00645-x","article-title":"A biologically stable DNAzyme that efficiently silences gene expression in cells","volume":"13","author":"Wang","year":"2021","journal-title":"Nature Chemistry"},{"issue":"1","key":"10.1016\/bs.apcsb.2024.11.012_bib249","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/nyas.14206","article-title":"The E3 ubiquitin ligase CHIP in normal cell function and in disease conditions","volume":"1460","author":"Wang","year":"2020","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1016\/bs.apcsb.2024.11.012_bib250","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.neuropharm.2012.03.004","article-title":"Adeno-associated virus (AAV) gene therapy for neurological disease","volume":"69","author":"Weinberg","year":"2013","journal-title":"Neuropharmacology"},{"issue":"5","key":"10.1016\/bs.apcsb.2024.11.012_bib251","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1073\/pnas.72.5.1858","article-title":"A protein factor essential for microtubule assembly","volume":"72","author":"Weingarten","year":"1975","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"4","key":"10.1016\/bs.apcsb.2024.11.012_bib252","first-page":"236","article-title":"Preclinical and clinical development of ABBV-8E12, a humanized anti-tau antibody, for treatment of Alzheimer\u2019s disease and other tauopathies","volume":"4","author":"West","year":"2017","journal-title":"The Journal of Prevention of Alzheimer\u2019s Disease"},{"issue":"13","key":"10.1016\/bs.apcsb.2024.11.012_bib253","doi-asserted-by":"crossref","first-page":"7120","DOI":"10.1073\/pnas.96.13.7120","article-title":"The tangled biology of tau","volume":"96","author":"Wilhelmsen","year":"1999","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"20","key":"10.1016\/bs.apcsb.2024.11.012_bib254","doi-asserted-by":"crossref","first-page":"11213","DOI":"10.1073\/pnas.93.20.11213","article-title":"Selective inhibition of Alzheimer disease-like tau aggregation by phenothiazines","volume":"93","author":"Wischik","year":"1996","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"3","key":"10.1016\/bs.apcsb.2024.11.012_bib255","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.3233\/JAD-170727","article-title":"Modeling prion-like processing of tau protein in Alzheimer\u2019s disease for pharmaceutical development","volume":"62","author":"Wischik","year":"2018","journal-title":"Journal of Alzheimer\u2019s Disease: JAD"},{"issue":"2","key":"10.1016\/bs.apcsb.2024.11.012_bib256","doi-asserted-by":"crossref","first-page":"705","DOI":"10.3233\/JAD-142874","article-title":"Tau aggregation inhibitor therapy: An exploratory phase 2 study in mild or moderate Alzheimer\u2019s disease","volume":"44","author":"Wischik","year":"2015","journal-title":"Journal of Alzheimer\u2019s Disease: JAD"},{"key":"10.1016\/bs.apcsb.2024.11.012_bib257","doi-asserted-by":"crossref","DOI":"10.6064\/2012\/796024","article-title":"The role of tau in neurodegenerative diseases and its potential as a therapeutic target","volume":"2012","author":"Wolfe","year":"2012","journal-title":"Scientifica"},{"issue":"8","key":"10.1016\/bs.apcsb.2024.11.012_bib258","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1038\/nn.4328","article-title":"Neuronal activity enhances tau propagation and tau pathology in vivo","volume":"19","author":"Wu","year":"2016","journal-title":"Nature Neuroscience"},{"issue":"1","key":"10.1016\/bs.apcsb.2024.11.012_bib259","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13024-021-00460-5","article-title":"Don\u2019t Phos Over Tau: Recent developments in clinical biomarkers and therapies targeting tau phosphorylation in Alzheimer\u2019s disease and other tauopathies","volume":"16","author":"Xia","year":"2021","journal-title":"Molecular Neurodegeneration"},{"issue":"48","key":"10.1016\/bs.apcsb.2024.11.012_bib260","doi-asserted-by":"crossref","first-page":"18488","DOI":"10.1074\/jbc.RA119.010178","article-title":"Impaired tau-microtubule interactions are prevalent among pathogenic tau variants arising from missense mutations","volume":"294","author":"Xia","year":"2019","journal-title":"The Journal of Biological Chemistry"},{"issue":"5","key":"10.1016\/bs.apcsb.2024.11.012_bib261","doi-asserted-by":"crossref","first-page":"343","DOI":"10.2174\/156652321405140926160602","article-title":"Tau silencing by siRNA in the P301S mouse model of tauopathy","volume":"14","author":"Xu","year":"2014","journal-title":"Current Gene Therapy"},{"issue":"16","key":"10.1016\/bs.apcsb.2024.11.012_bib262","doi-asserted-by":"crossref","first-page":"7787","DOI":"10.1073\/pnas.91.16.7787","article-title":"Glycated tau protein in Alzheimer disease: A mechanism for induction of oxidant stress","volume":"91","author":"Yan","year":"1994","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.apcsb.2024.11.012_bib263","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2021.104988","article-title":"Role of the endolysosomal pathway and exosome release in tau propagation","volume":"145","author":"Yan","year":"2021","journal-title":"Neurochemistry International"},{"issue":"4","key":"10.1016\/bs.apcsb.2024.11.012_bib264","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.molcel.2008.07.002","article-title":"Lysine acetylation: Codified crosstalk with other posttranslational modifications","volume":"31","author":"Yang","year":"2008","journal-title":"Molecular Cell"},{"key":"10.1016\/bs.apcsb.2024.11.012_bib265","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2024.115363","article-title":"Adeno-associated virus vector delivery to the brain: Technology advancements and clinical applications","volume":"211","author":"Ye","year":"2024","journal-title":"Advanced Drug Delivery Reviews"},{"issue":"4","key":"10.1016\/bs.apcsb.2024.11.012_bib266","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1750-3639.1999.tb00551.x","article-title":"Fibrillogenesis of tau: Insights from tau missense mutations in FTDP-17","volume":"9","author":"Yen","year":"1999","journal-title":"Brain Pathology (Zurich, Switzerland)"},{"issue":"8","key":"10.1016\/bs.apcsb.2024.11.012_bib267","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.chembiol.2016.04.014","article-title":"Stabilizing the Hsp70-Tau complex promotes turnover in models of tauopathy","volume":"23","author":"Young","year":"2016","journal-title":"Cell Chemical Biology"},{"issue":"3","key":"10.1016\/bs.apcsb.2024.11.012_bib268","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1139\/bcb-2016-0227","article-title":"Structural evaluations of tau protein conformation: Methodologies and approaches","volume":"95","author":"Zabik","year":"2017","journal-title":"Biochemistry and Cell Biology = Biochimie et Biologie Cellulaire"},{"issue":"11","key":"10.1016\/bs.apcsb.2024.11.012_bib269","doi-asserted-by":"crossref","DOI":"10.1083\/jcb.202006054","article-title":"The proline-rich domain promotes Tau liquid-liquid phase separation in cells","volume":"219","author":"Zhang","year":"2020","journal-title":"The Journal of Cell Biology"},{"issue":"1","key":"10.1016\/bs.apcsb.2024.11.012_bib270","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s40035-024-00429-6","article-title":"Tau in neurodegenerative diseases: Molecular mechanisms, biomarkers, and therapeutic strategies","volume":"13","author":"Zhang","year":"2024","journal-title":"Translational Neurodegeneration"},{"key":"10.1016\/bs.apcsb.2024.11.012_bib271","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15295","article-title":"Tau association with synaptic vesicles causes presynaptic dysfunction","volume":"8","author":"Zhou","year":"2017","journal-title":"Nature Communications"},{"issue":"3","key":"10.1016\/bs.apcsb.2024.11.012_bib272","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/ptr.6257","article-title":"Curcumin intervention for cognitive function in different types of people: A systematic review and meta-analysis","volume":"33","author":"Zhu","year":"2019","journal-title":"Phytotherapy Research: PTR"},{"issue":"28","key":"10.1016\/bs.apcsb.2024.11.012_bib273","doi-asserted-by":"crossref","first-page":"25108","DOI":"10.1074\/jbc.M110.187591","article-title":"Tumor necrosis factor receptor-associated factor 6 (TRAF6) associates with huntingtin protein and promotes its atypical ubiquitination to enhance aggregate formation","volume":"286","author":"Zucchelli","year":"2011","journal-title":"The Journal of Biological Chemistry"}],"container-title":["Advances in Protein Chemistry and Structural Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876162324001354?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876162324001354?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T13:27:16Z","timestamp":1750685236000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1876162324001354"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":273,"URL":"https:\/\/doi.org\/10.1016\/bs.apcsb.2024.11.012","relation":{},"ISSN":["1876-1623"],"issn-type":[{"value":"1876-1623","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]}}}